Divi Overlays

Esin has served as Biodexa’s VP, Regulatory Affairs & Quality Assurance since June 2025. In this role, she brings more than 25 years of global regulatory affairs leadership experience, including a strong track record in the successful development and registration of...

Jim brings approximately 30 years of global clinical development experience covering all phases in the oncologic and rare disease space in both the Pharmaceutical/Biotech and CRO industries. Prior to joining Biodexa Pharmaceuticals, Jim served as the SVP Clinical...

Gary Shangold MD is a board-certified Obstetrician/Gynecologist and Reproductive Endocrinologist who is newly-appointed as Chief Medical Officer for Biodexa Pharmaceuticals PLC. His career in the pharmaceutical industry spans more than 30 years, including senior...

Ann Merchant served as Vice President for MorphoSys AG from 2018 until April 2025, most recently as Head of Global Supply Chain and External Operations. Prior to joining MorphoSys, from September 2011 to August 2018, Ms. Merchant served as the President of Schreiner...

Noreen brings over 27 years’ global clinical development experience covering all phases in a broad range of therapeutic areas in both the Pharmaceutical and CRO industries. Prior to joining Biodexa Pharmaceuticals, she has successfully led an oncology registrational...

Dr. de Vries has extensive senior level experience in both the pharmaceutical and biotechnology industry. Following more than 16 years as CEO of Pharming group N.V., the Dutch Euronext-listed bio-pharmaceutical company, in October 2024, he announced to not be up for...

Dr Turton previously headed Warburg Pincus’ healthcare investing activities in Europe and was a principal at Index Ventures in Geneva. He has over 10 years of experience investing in biopharma companies following a ten-year career in the international pharmaceutical...

Stephen Parker has over 35 years’ experience in leadership roles both in the healthcare industry and in advisory roles. Currently, he is Executive Chairman of Sareum Holdings plc (AIM: SAR) and Non-Executive Chairman of Drishti Discoveries Ltd. He is also an Executive...

A chemist by training, Steve has spent more than 30 years in commercially focused roles across multiple sectors of the pharmaceutical industry. Steve has led commercial teams at drug delivery organisations, including Eurand and Bespak, and has held senior roles at...

Fiona is a qualified accountant and has held senior finance positions within the PR and advertising industry, including Group Finance Director of Chime Communications Group. Fiona is a Fellow of the Chartered Association of Certified Accountants.

Dan has 17 years experience in the biotech sector with particular focus on drug delivery and nanotechnologies for oncology. He has managed interdisciplinary R&D programmes across biology, chemistry and engineering. As well as leading Biodexa Pharmaceuticals’...

Mr. Stamp is an experienced public company CFO and has held senior positions in a number of significant healthcare companies including as Group Finance Director of Shire plc, Chief Operating Officer of Xanodyne Pharmaceuticals Inc and most recently with AIM quoted...